Cong Xu

Cong Xu

41 år
Health Technology
Consumer Services

Profil

Cong Xu is currently Chairman at IMPACT Therapeutics, Inc. since 2020.
Dr. Xu is a Non-Executive Director at EdiGene Inc. since 2018 and at ImmuneOnco Biopharmaceuticals (Shanghai), Inc. since 2020.
Dr. Xu is a Director at Shanghai Kechow Pharma, Inc. and Shanghai Allist Pharmaceuticals Co., Ltd., both since 2024.
Formerly, Dr. Xu was a Director at Arrivent BioPharma, Inc. from 2022 to 2023.
Dr. Xu earned a doctorate from Clemson University in 2012, a doctorate from the University of British Columbia in 2018, and an undergraduate degree from Tongji Medical College of Huazhong University of Science & Technology in 2007.

Aktiva positioner av Cong Xu

FöretagPositionStart
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. Direktör/Styrelseledamot 2020-10-01
IMPACT THERAPEUTICS, INC Ordförande 2020-07-01
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. Direktör/Styrelseledamot 2024-11-26
Direktör/Styrelseledamot 2024-07-12
Direktör/Styrelseledamot 2018-01-01

Tidigare kända positioner av Cong Xu

FöretagPositionSlut
ARRIVENT BIOPHARMA, INC. Direktör/Styrelseledamot 2023-12-01
Se detaljerna i Cong Xus erfarenhet

Cong Xus utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

65

Första gradens relationer

9

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag9

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology